Feel that you need a fortune to invest in order to yield massive returns? Not necessarily! The discovery of creative companies with high potential for growth may be crucial even with a reduced amount. Based on the latest analysis, here are two healthcare stocks for which $200 may be the perfect number to get the ball rolling in the direction of long-term gains:

1. TransMedics Group (TMDX)

This company is transforming organ transplant with the Organ Care System (OCS), a revolutionary technique for keeping organs viable for longer than conventional cold storage. The OCS has demonstrated a much better rate of success in clinical trials for organs such as hearts. Although TransMedics experienced the recent hiccups and stock decline, it is recovering, and its technology makes it ready for more expansion in the likelihood of increasing organ donation. One share will give you access to this innovative market; at around $122 per share, $200 buys you a share.

2. Exact Sciences (EXAS)

Exact Sciences is an industry leader in cancer detection, most famous for Cologuard, the at-home test for colorectal cancer. This is important because early detection will save lives. Despite the company’s past revenue problems, the company has great new catalysts. They have introduced the better Cologuard Plus (which is also affordable to produce) and a recurrence test known as Oncodetect; a multi-cancer test is in the works. These new products are likely to push higher growth and future profits. As the shares are going for about $54, $200 can buy three of this diagnostics innovator.

Verdict

TransMedics Group and Exact Sciences are innovative companies with the technology that serves key healthcare needs. Although the past does not promise the future, their growth possibilities make them attractive stocks to invest $200 in for the next five years and more.